Table 1.
Characteristic | Experimental group (n = 41) | Control group (n = 42) | P | |
---|---|---|---|---|
Gender | Male | 30 | 31 | 0.947 |
Female | 11 | 11 | ||
Age (Years) | Range | 23-70 | 22-70 | 0.297 |
ECOG score | 0 | 11 | 8 | 0.399 |
1 | 30 | 34 | ||
Pathological types | Keratinized carcinoma | 0 | 1 | 0.676 |
Non-keratinizing carcinoma | 38 | 37 | ||
Undifferentiated type | 2 | 4 | ||
Adenoid cystic carcinoma | 1 | 0 | ||
Clinical stagea | III | 15 | 17 | 0.716 |
IVa | 26 | 25 | ||
T staging | T1 | 3 | 4 | 0.910 |
T2 | 14 | 12 | ||
T3 | 15 | 15 | ||
T4 | 9 | 11 | ||
N staging | N1 | 3 | 2 | 0.830 |
N2 | 20 | 19 | ||
N3 | 18 | 21 |
Staging is based on the American Joint Commission on Cancer (AJCC) eighth edition of the TNM staging system in 2018.